Advances in the treatment of central serous chorioretinopathy
SJO-Saudi Journal of Ophthalmology. 2015; 29 (4): 278-286
in English
| IMEMR
| ID: emr-173803
ABSTRACT
Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to various treatment models. Enhanced depth imaging optical coherence tomography, in particular, has helped in observing choroidal thickness changes after various treatment models. To date, photodynamic therapy and focal laser remain the main stay of treatment. More understanding of disease pathophysiology in the future will help in determining the drug of choice and the best management option for such cases
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Photochemotherapy
/
Adrenal Cortex Hormones
/
Central Serous Chorioretinopathy
/
Light Coagulation
Limits:
Humans
Language:
English
Journal:
Saudi J. Ophthalmol.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS